PE20091224A1 - Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat y su procedimiento de preparacion - Google Patents

Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat y su procedimiento de preparacion

Info

Publication number
PE20091224A1
PE20091224A1 PE2007001452A PE2007001452A PE20091224A1 PE 20091224 A1 PE20091224 A1 PE 20091224A1 PE 2007001452 A PE2007001452 A PE 2007001452A PE 2007001452 A PE2007001452 A PE 2007001452A PE 20091224 A1 PE20091224 A1 PE 20091224A1
Authority
PE
Peru
Prior art keywords
mixtures
weight
pharmaceutical composition
sodium
talc
Prior art date
Application number
PE2007001452A
Other languages
English (en)
Spanish (es)
Inventor
Urzua Marcos Morales
Chen Shu Chen
Apablaza Marianela Beltran
Original Assignee
Andromaco Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51359501&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20091224(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Andromaco Lab filed Critical Andromaco Lab
Publication of PE20091224A1 publication Critical patent/PE20091224A1/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PE2007001452A 2007-08-06 2007-10-25 Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat y su procedimiento de preparacion PE20091224A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2007002287A CL53426B (fr) 2007-08-06 2007-08-06

Publications (1)

Publication Number Publication Date
PE20091224A1 true PE20091224A1 (es) 2009-08-26

Family

ID=51359501

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007001452A PE20091224A1 (es) 2007-08-06 2007-10-25 Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat y su procedimiento de preparacion

Country Status (7)

Country Link
CL (1) CL53426B (fr)
CR (1) CR10132A (fr)
DO (1) DOP2008000021A (fr)
MX (1) MX2008010082A (fr)
PA (1) PA8786701A1 (fr)
PE (1) PE20091224A1 (fr)
SV (1) SV2009002991A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL216542B1 (pl) * 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku

Also Published As

Publication number Publication date
PA8786701A1 (es) 2009-04-23
CL2007002287A1 (fr) 2007-12-14
DOP2008000021A (es) 2009-11-30
MX2008010082A (es) 2009-04-17
SV2009002991A (es) 2009-04-16
CL53426B (fr) 2016-11-28
CR10132A (es) 2008-10-28

Similar Documents

Publication Publication Date Title
UA97489C2 (ru) Фармацевтическая композиция, которая содержит аморфный розувастатин кальция
HK1147202A1 (en) Orally disintegrated dosage form
PE20070165A1 (es) Formulacion de comprension directa que comprende un inhibidor de dipeptidil-peptidasa iv y una glitazona
GT200600194A (es) Composiciones farmaceuticas conteniendo imatinib y un componente de liberacion prolongada
PE20201496A1 (es) Composiciones y metodos para tratar anemia
ATE493412T1 (de) Spirohydantoin-aryl-cgrp-rezeptorantagonisten
HRP20211752T1 (hr) Farmaceutski pripravci 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il)ciklopropankarboksamido)-3-metilpiridin-2-il)benzojeve kiseline i njihova primjena
PE20030602A1 (es) Composicion farmaceutica que comprende un macrolido
DE602005020655D1 (de) Carboxamid-spirolactam-cgrp-rezeptor-antagonisten
EA200971081A1 (ru) Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7
ATE537170T1 (de) Cgrp-rezeptorantagonisten
RS54329B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING RIFAXIMINE, PROCEDURES FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS
TN2012000246A1 (en) Pharmaceutical compositions comprising sigma receptor ligands
PT2323972E (pt) Compostos de tetraciclina substituídos com c7-flúor
CR9953A (es) Diarilurea para el tratamiento de hipertension pulmonar
RU2008135718A (ru) Композиции клопидогреля бисульфата
RS54244B1 (en) NALBUFINE BASED FORMULATIONS AND THEIR USE
DK1996160T3 (da) Bioresorberbar sammensætning med kontrolleret frigivelse
IN2012DN02502A (fr)
AR077546A1 (es) Formulaciones de comprimidos de 3-cianoquinolina y usos de los mismos
MX2011011928A (es) Procedimiento y composicion para mejorar la absorcion de agentes terapeuticos.
AR061093A1 (es) Composiciones de calcio
TN2010000585A1 (en) Pharmaceutical compositions of rosuvastatin calcium
ES2922903T3 (es) Composición farmacéutica que comprende sales de lenvatinib
PE20091224A1 (es) Composicion farmaceutica en la forma de polvos encapsulados que comprende orlistat y su procedimiento de preparacion

Legal Events

Date Code Title Description
FG Grant, registration